{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T00:26:20Z","timestamp":1776471980759,"version":"3.51.2"},"reference-count":45,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2023,3,14]],"date-time":"2023-03-14T00:00:00Z","timestamp":1678752000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccines"],"abstract":"<jats:p>Purpose: To report a case of severe mpox in a newly diagnosed HIV patient concerning for Immune Reconstitution Inflammatory Syndrome (IRIS) and\/or tecovirimat resistance and to describe the management approach in the setting of refractory disease. Case: 49-year-old man presented with 2 weeks of perianal lesions. He tested positive for mpox PCR in the emergency room and was discharged home with quarantine instructions. Three weeks later, the patient returned with disseminated firm, nodular lesions in the face, neck, scalp, mouth, chest, back, legs, arms, and rectum, with worsening pain and purulent drainage from the rectum. The patient reported being on 3 days of tecovirimat treatment, which was prescribed by the Florida department of health (DOH). During this admission, he was found to be HIV positive. A pelvic CT scan revealed a 2.5 cm perirectal abscess. Treatment with tecovirimat was continued for 14 days, along with an empiric course of antibiotics for treatment of possible superimposed bacterial infection upon discharge. He was seen in the outpatient clinic and initiated antiretroviral therapy (ART) with TAF\/emtricitabine\/bictegravir. Two weeks after starting ART, the patient was readmitted for worsening mpox rash and rectal pain. Urine PCR also returned positive for chlamydia, for which the patient was prescribed doxycycline. He was discharged on a second course of tecovirimat and antibiotic therapy. Ten days later, the patient was readmitted for the second time due to worsening symptoms and blockage of the nasal airway from progressing lesions. At this point, there were concerns for tecovirimat resistance, and after discussion with CDC, tecovirimat was reinitiated for the third time, with the addition of Cidofovir and Vaccinia, and showed an improvement in his symptoms. He received three doses of cidofovir and two doses of Vaccinia, and the patient was then discharged to complete 30 days of tecovirimat. Outpatient follow-up showed favorable outcomes and near resolution. Conclusion: We reported a challenging case of worsening mpox after Tecovirimat treatment in the setting of new HIV and ART initiation concerning IRIS vs. Tecovirimat resistance. Clinicians should consider the risk of IRIS and weigh the pros and cons of initiating or delaying ART. In patients not responding to first-line treatment with tecovirimat, resistance testing should be performed, and alternative options should be considered. Future research is needed to establish guidance on the role of Cidofovir and Vaccinia immune globulin and the continuation of tecovirimat for refractory mpox.<\/jats:p>","DOI":"10.3390\/vaccines11030650","type":"journal-article","created":{"date-parts":[[2023,3,14]],"date-time":"2023-03-14T06:14:58Z","timestamp":1678774498000},"page":"650","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Successful Outcome after Treatment with Cidofovir, Vaccinia, and Extended Course of Tecovirimat in a Newly-Diagnosed HIV Patient with Severe Mpox: A Case Report"],"prefix":"10.3390","volume":"11","author":[{"given":"Andres","family":"Martinez","sequence":"first","affiliation":[{"name":"Division of Infectious Diseases, Department of Medicine, Jackson Memorial Hospital, Miami, FL 33136, USA"},{"name":"Division of Infectious Diseases, Department of Medicine, Miller School of Medicine, University of Miami, Miami, FL 33146, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paola","family":"Frattaroli","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Medicine, Jackson Memorial Hospital, Miami, FL 33136, USA"},{"name":"Division of Infectious Diseases, Department of Medicine, Miller School of Medicine, University of Miami, Miami, FL 33146, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine","family":"Vu","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Jackson Memorial Hospital, Miami, FL 33136, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lizy","family":"Paniagua","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Medicine, Jackson Memorial Hospital, Miami, FL 33136, USA"},{"name":"Division of Infectious Diseases, Department of Medicine, Miller School of Medicine, University of Miami, Miami, FL 33146, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joel","family":"Mintz","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University of Miami, Jackson Memorial Hospital, Miami, FL 33136, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andres","family":"Bravo-Gonzalez","sequence":"additional","affiliation":[{"name":"CES University, Medellin, Antioquia 050007, Colombia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-0749-4532","authenticated-orcid":false,"given":"Paola","family":"Zamudio","sequence":"additional","affiliation":[{"name":"Universidad An\u00e1huac Quer\u00e9taro, Quer\u00e9taro 76246, Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Astrid","family":"Barco","sequence":"additional","affiliation":[{"name":"Universidad de Especialidades Esp\u00edritu Santo, Guayas 092301, Ecuador"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aruna","family":"Rampersad","sequence":"additional","affiliation":[{"name":"Couva Hospital and Multi Training Facility, Couva 550214, Trinidad and Tobago"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paola","family":"Lichtenberger","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Medicine, Jackson Memorial Hospital, Miami, FL 33136, USA"},{"name":"Division of Infectious Diseases, Department of Medicine, Miller School of Medicine, University of Miami, Miami, FL 33146, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2768-9712","authenticated-orcid":false,"given":"Jose","family":"Gonzales-Zamora","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Medicine, Jackson Memorial Hospital, Miami, FL 33136, USA"},{"name":"Division of Infectious Diseases, Department of Medicine, Miller School of Medicine, University of Miami, Miami, FL 33146, USA"},{"name":"Peruvian American Medical Society (PAMS), Albuquerque, NM 87111, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2023,3,14]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.7326\/M22-1581","article-title":"A Novel International Monkeypox Outbreak","volume":"175","author":"Adalja","year":"2022","journal-title":"Ann. Intern. Med."},{"key":"ref_2","unstructured":"(2022, October 27). Genital Monkeypox Superimposed on Co-Incident Sexually Transmitted Infections in AIDS Patient; A Case Report-PMC, Available online: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC9523066\/?report=classic."},{"key":"ref_3","unstructured":"CDC (2022, October 27). Monkeypox in the U.S. Centers for Disease Control and Prevention, Available online: https:\/\/www.cdc.gov\/poxvirus\/monkeypox\/index.html."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.15585\/mmwr.mm7132e3","article-title":"Epidemiologic and Clinical Characteristics of Monkeypox Cases-United States, May 17\u2013July 22, 2022","volume":"71","author":"Philpott","year":"2022","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.15585\/mmwr.mm7135e2","article-title":"Modeling the Impact of Sexual Networks in the Transmission of Monkeypox virus Among Gay, Bisexual, and Other Men Who Have Sex with Men\u2014United States, 2022","volume":"71","author":"Spicknall","year":"2022","journal-title":"Morb. Mortal. Wkly. Rep."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Alakunle, E., Moens, U., Nchinda, G., and Okeke, M.I. (2020). Monkeypox Virus in Nigeria: Infection Biology, Epidemiology, and Evolution. Viruses, 12.","DOI":"10.3390\/v12111257"},{"key":"ref_7","unstructured":"Petersen, B., Agam, R., and Yom, Y. (2022, November 10). Guidance for Tecovirimat Use (2023) Centers for Disease Control and Prevention, Available online: https:\/\/www.cdc.gov\/poxvirus\/mpox\/clinicians\/Tecovirimat.html#references."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"e01626","DOI":"10.1016\/j.idcr.2022.e01626","article-title":"Severe monkeypox with superimposed bacterial infection in an immunocompetent patient: A case report","volume":"30","author":"Manoharan","year":"2022","journal-title":"IDCases"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Hoffmann, C., Jessen, H., Wyen, C., Grunwald, S., Noe, S., Teichmann, J., Krauss, A., Kolarikal, H., Scholten, S., and Schuler, C. (2022). Clinical characteristics of monkeypox virus infections among men with and without HIV: A large outbreak cohort in Germany. HIV Med.","DOI":"10.1111\/hiv.13378"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1016\/j.jinf.2022.08.014","article-title":"First case of monkeypox virus, SARS-CoV-2 and HIV co-infection","volume":"86","author":"Nolasco","year":"2023","journal-title":"J. Infect."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1086\/499356","article-title":"Incidence and risk factors for immune reconstitution inflammatory syndrome in an ethnically diverse HIV type 1-infected cohort","volume":"42","author":"Ratnam","year":"2006","journal-title":"Clin. Infect. Dis."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"447","DOI":"10.7326\/0003-4819-133-6-200009190-00013","article-title":"Inflammatory Reactions in HIV-1\u2013Infected Persons after Initiation of Highly Active Antiretroviral Therapy","volume":"133","author":"DeSimone","year":"2000","journal-title":"Ann. Intern. Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1093\/cid\/ciz877","article-title":"Prospective International Study of Incidence and Predictors of Immune Reconstitution Inflammatory Syndrome and Death in People Living with Human Immunodeficiency Virus and Severe Lymphopenia","volume":"71","author":"Sereti","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.15585\/mmwr.mm7136a1","article-title":"HIV and Sexually Transmitted Infections Among Persons with Monkeypox\u2014Eight U.S. Jurisdictions, May 17\u2013July 22, 2022","volume":"71","author":"Curran","year":"2022","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1056\/NEJMoa2207323","article-title":"Monkeypox Virus Infection in Humans across 16 Countries\u2014April\u2013June 2022","volume":"387","author":"Thornhill","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"106897","DOI":"10.1016\/j.ijsu.2022.106897","article-title":"Monkeypox virus crosstalk with HIV; where do we stand now?","volume":"105","author":"Shafaati","year":"2022","journal-title":"Int. J. Surg."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"549","DOI":"10.3947\/ic.2022.0104","article-title":"Monkeypox in HIV Infected Cases: A Summary on Clinical Presentation of 27 Cases","volume":"54","author":"Mungmunpuntipantip","year":"2022","journal-title":"Infect. Chemother."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1056\/NEJMra2208860","article-title":"Monkeypox","volume":"387","author":"Gessain","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"ref_19","first-page":"610","article-title":"Clinical presentation of Monkeypox among people living with HIV in South Florida: A case series","volume":"4","author":"Wong","year":"2022","journal-title":"Infez Med."},{"key":"ref_20","first-page":"872","article-title":"Outbreak of human monkeypox in Nigeria in 2017-18: A clinical and epidemiological report","volume":"8","author":"Aruna","year":"2019","journal-title":"Lancet Infect. Dis."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"e210","DOI":"10.1093\/cid\/ciaa143","article-title":"Clinical Course and Outcome of Human Monkeypox in Nigeria","volume":"71","author":"Ogoina","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1097\/01.aids.0000131375.21070.06","article-title":"Immune restoration disease after antiretroviral therapy","volume":"18","author":"French","year":"2004","journal-title":"AIDS"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/S1473-3099(14)70733-9","article-title":"Early versus delayed initiation of highly active antiretroviral therapy for HIV-positive adults with newly diagnosed pulmonary tuberculosis (TB-HAART): A prospective, international, randomised, placebo-controlled trial","volume":"14","author":"Mfinanga","year":"2014","journal-title":"Lancet Infect. Dis."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"3818","DOI":"10.1182\/blood-2010-05-285080","article-title":"Elevated frequencies of highly activated CD4+ T cells in HIV+ patients developing immune reconstitution inflammatory syndrome","volume":"116","author":"Antonelli","year":"2010","journal-title":"Blood"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1258\/ijsa.2008.008428","article-title":"Pneumocystis-associated organizing pneumonia as a manifestation of immune reconstitution inflammatory syndrome in an HIV-infected individual with a normal CD4+ T-cell count following antiretroviral therapy","volume":"20","author":"Mori","year":"2009","journal-title":"Int. J. STD AIDS"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/S1473-3099(14)71028-X","article-title":"TB-HAART trial","volume":"15","author":"Lederer","year":"2015","journal-title":"Lancet Infect. Dis."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"e13016","DOI":"10.1097\/MD.0000000000013016","article-title":"Integrase inhibitor-based regimens result in more rapid virologic suppression rates among treatment-na\u00efve human immunodeficiency virus\u2013infected patients compared to non-nucleoside and protease inhibitor\u2013based regimens in a real-world clinical setting","volume":"97","author":"Jacobson","year":"2018","journal-title":"Medicine"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1097\/QAI.0000000000002937","article-title":"Risk of immune reconstitution inflammatory syndrome with integrase inhibitors versus other classes of antiretrovirals: A systematic review and meta-analysis of randomised trials","volume":"90","author":"Zhao","year":"2022","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.cmi.2022.09.017","article-title":"Haemorrhagic monkeypox infection in an immunosuppressed patient with human immunodeficiency virus: Beyond the pustules","volume":"29","year":"2023","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.jinf.2022.06.028","article-title":"Monkeypox and pan-resistant Campylobacter spp infection in Entamoeba histolytica and Chlamydia trachomatis re-infection in a man who have sex with men","volume":"85","author":"Raccagni","year":"2022","journal-title":"J. Infect."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ijid.2018.03.016","article-title":"Clinical diagnostic and therapeutic aspects of 221 consecutive anorectal Chlamydia trachomatis and Neisseria gonorrhoeae sexually transmitted infections among men who have sex with men","volume":"71","author":"Hascoet","year":"2018","journal-title":"Int. J. Infect. Dis."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"102469","DOI":"10.1016\/j.tmaid.2022.102469","article-title":"Monkeypox proctitis treated with doxycycline in an HIV MSM returning to Italy from France","volume":"50","author":"Trizzino","year":"2022","journal-title":"Travel Med. Infect. Dis."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"e1424","DOI":"10.1093\/cid\/ciac713","article-title":"Infectious Proctitis due to Human Monkeypox","volume":"76","author":"Gedela","year":"2023","journal-title":"Clin. Infect. Dis."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.15585\/mmwr.mm7132e4","article-title":"Interim Guidance for Prevention and Treatment of Monkeypox in Persons with HIV Infection\u2014United States, August 2022","volume":"71","author":"Filardo","year":"2022","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1056\/NEJMoa1705688","article-title":"Oral Tecovirimat for the Treatment of Smallpox","volume":"379","author":"Grosenbach","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.15585\/mmwr.mm7144e1","article-title":"Severe Monkeypox in Hospitalized Patients-United States, 10 August\u201310 October 2022","volume":"71","author":"Miller","year":"2022","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"e0122622","DOI":"10.1128\/aac.01226-22","article-title":"New Perspectives on Antimicrobial Agents: Tecovirimat for Treatment of Human Monkeypox Virus","volume":"66","author":"DeLaurentis","year":"2022","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_38","unstructured":"(2022, October 24). CDC Health Update-DHHS. Update on Managing Monkeypox in Patients Receiving Therapeutics, Available online: https:\/\/dhhs.ne.gov\/han%20Documents\/UPDATE11182022.pdf."},{"key":"ref_39","first-page":"A27","article-title":"17th International Conference on Antiviral Research In: Successful cidofovir treatment of smallpox-like disease in variola and monkeypox primate models","volume":"62","author":"Huggins","year":"2004","journal-title":"Antivir. Res."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1038\/nature04295","article-title":"Antiviral treatment is more effective than smallpox vaccination upon lethal monkeypox virus infection","volume":"439","author":"Stittelaar","year":"2006","journal-title":"Nature"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"e28218","DOI":"10.1002\/jmv.28218","article-title":"Real-life use of cidofovir for the treatment of severe monkeypox cases","volume":"1","author":"Raccagni","year":"2023","journal-title":"J. Med. Virol."},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Stafford, A., Rimmer, S., Gilchrist, M., Sun, K., Davies, E.P., Waddington, C.S., Chiu, C., Armstrong-James, D., Swaine, T., and Davies, F. (2023). Use of cidofovir in a patient with severe mpox and uncontrolled HIV infection. Lancet Infect. Dis.","DOI":"10.1016\/S1473-3099(23)00044-0"},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Fabrizio, C., Bruno, G., Cristiano, L., and Buccoliero, G.B. (Infection, 2022). Cidofovir for treating complicated monkeypox in a man with acquired immune deficiency syndrome, Infection, Epub ahead of print.","DOI":"10.21203\/rs.3.rs-1999347\/v1"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jinf.2022.11.001","article-title":"Clinical experience with use of oral Tecovirimat or Intravenous Cidofovir for the treatment of Monkeypox in an Italian reference hospital","volume":"86","author":"Mondi","year":"2023","journal-title":"J. Infect."},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Thet, A.K., Kelly, P.J., Kasule, S.N., Shah, A.K., Chawala, A., Latif, A., Chilimuri, S.S., and Zeana, C.B. (2022). The Use of Vaccinia Immune Globulin in the Treatment of Severe Monkeypox Virus Infection in HIV\/AIDS. Clin. Infect. Dis., ciac971.","DOI":"10.1093\/cid\/ciac971"}],"container-title":["Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-393X\/11\/3\/650\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T18:54:35Z","timestamp":1760122475000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-393X\/11\/3\/650"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,14]]},"references-count":45,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2023,3]]}},"alternative-id":["vaccines11030650"],"URL":"https:\/\/doi.org\/10.3390\/vaccines11030650","relation":{},"ISSN":["2076-393X"],"issn-type":[{"value":"2076-393X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,14]]}}}